News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Pauline T. Merrill, MD, FASRS

Advertisement

Articles by Pauline T. Merrill, MD, FASRS

Enhancing patient outcomes

ByPauline T. Merrill, MD, FASRS
June 20th 2024
Advertisement

Latest Updated Articles

  • Enhancing patient outcomes
    Enhancing patient outcomes

    Published: June 20th 2024 | Updated:



Advertisement
Advertisement

Trending on Modern Retina

1

Evolving strategies in retinal care: Navigating today’s treatment landscape

2

Regeneron receives another CRL for its Eylea 8 mg

3

Iron dysregulation may drive AMD, new study results show

4

ONL Therapeutics randomly assigns first patient in phase 2 GALAXY trial evaluating xelafaslatide

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us